Abstract
1. The activity of a new anti-allergic compound, I.C.I. 74,917, has been studied in the rat, mouse and guinea-pig. 2. Following intravenous administration, I.C.I. 74,917 inhibits in a dose-dependent manner passive cutaneous anaphylaxis induced in rats and mice by heat-labile homocytotropic antibody. In rats, its potency is approximately 300 times that of disodium cromoglycate. 3. To achieve maximal inhibition, it is necessary to administer I.C.I. 74,917 at the same time as antigenic challenge; dosing before or after challenge has much less effect. 4. Liberation of histamine, provoked by the antigenic challenge of mast cells passively sensitized in vitro by IgE-like antibody, is reduced in the presence of I.C.I. 74,917. 5. Intravenous administration of the compound has no significant effect upon local blueing reactions provoked in the rat by intradermal injection of histamine, 5-hydroxytryptamine or Compound 48/80. It has only a slight effect at high doses upon passive cutaneous anaphylaxis induced in the rat by heat-stable homocytotropic or heterologous (guinea-pig) antibodies. 6. Although not a bronchodilator in the guinea-pig, I.C.I. 74,917 partially inhibits systemic anaphylaxis. A consistent reduction in the severity of antigen-induced bronchospasm was demonstrated in the Konzett-Rossler preparation at doses comparable to those inhibiting passive cutaneous anaphylaxis in the rat. However, there was only slight inhibition of passive cutaneous anaphylaxis in the guinea-pig. 7. I.C.I. 74,917 itself induces bronchospasm when administered to anaesthetized guinea-pigs or to a guinea-pig isolated lung preparation. This effect is reversed by salbutamol, but is not prevented by the prior administration of mepyramine, atropine or methysergide. 8. These results indicate that in the rat, mouse and guinea-pig, I.C.I. 74,917 is a potent inhibitor of certain types of immediate hypersensitivity reactions.
Full text
PDF









Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Assem E. S. Inhibition of allergic reactions by cromoglycate and by a new series of compounds (AH 6556, AH 7079 and AH 7725). Int Arch Allergy Appl Immunol. 1973;45(5):708–718. doi: 10.1159/000231070. [DOI] [PubMed] [Google Scholar]
- BHATTACHARYA B. K., DELAUNOIS A. L. An improved method for the perfusion of isolated lung of guinea pig. Arch Int Pharmacodyn Ther. 1955 May 1;101(4):495–501. [PubMed] [Google Scholar]
- Buckle D. R., Morgan N. J., Ross J. W., Smith H., Spicer B. A. Antiallergic activity of 2-nitroindan-1,3-diones. J Med Chem. 1973 Dec;16(12):1334–1339. doi: 10.1021/jm00270a005. [DOI] [PubMed] [Google Scholar]
- Collier H. O., James G. W. Humoral factors affecting pulmonary inflation during acute anaphylaxis in the guinea-pig in vivo. Br J Pharmacol Chemother. 1967 Jun;30(2):283–301. doi: 10.1111/j.1476-5381.1967.tb02135.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Colquhoun D., Brocklehurst W. E. Passive sensitization of skin and lung by guinea-pig immunoglobulins. Immunology. 1965 Dec;9(6):591–611. [PMC free article] [PubMed] [Google Scholar]
- Cox J. S., Beach J. E., Blair A. M., Clarke A. J., King J., Lee T. B., Loveday D. E., Moss G. F., Orr T. S., Ritchie J. T. Disodium cromoglycate (Intal). Adv Drug Res. 1970;5:115–196. [PubMed] [Google Scholar]
- Cox J. S. Disodium cromoglycate (FPL 670) ('Intal'): a specific inhibitor of reaginic antibody-antigen mechanisms. Nature. 1967 Dec 30;216(5122):1328–1329. doi: 10.1038/2161328a0. [DOI] [PubMed] [Google Scholar]
- Cox J. S. Disodium cromoglycate. Mode of action and its possible relevance to the clinical use of the drug. Br J Dis Chest. 1971 Oct;65(4):189–204. doi: 10.1016/0007-0971(71)90028-3. [DOI] [PubMed] [Google Scholar]
- Davies G. E. Antibronchoconstrictor activity of two new phosphodiesterase inhibitors, a triazolopyrazine (ICI 58 301) and a triazolopyrimidine (ICI 63 197). J Pharm Pharmacol. 1973 Sep;25(9):681–689. doi: 10.1111/j.2042-7158.1973.tb10048.x. [DOI] [PubMed] [Google Scholar]
- Davies G. E., Evans D. P. Studies with two new phosphodiesterase inhibitors (ICI 58, 301 and ICI 63, 197) on anaphylaxis in guinea pigs, mice and rats. Int Arch Allergy Appl Immunol. 1973;45(3):467–478. doi: 10.1159/000231064. [DOI] [PubMed] [Google Scholar]
- Davies G. E., Johnston T. P. Quantitative studies on anaphylaxis in guinea-pigs passively sensitized with homologous antibody. Int Arch Allergy Appl Immunol. 1971;41(5):648–654. doi: 10.1159/000230557. [DOI] [PubMed] [Google Scholar]
- Evans D. P., Gilman D. J., Thomson D. S., Waring W. S. Inhibition of allergic reactions by a novel phenanthroline ICI 74,917. Nature. 1974 Aug 16;250(467):592–593. doi: 10.1038/250592a0. [DOI] [PubMed] [Google Scholar]
- Evans D. P., Lewis J. A., Thomson D. S. An automated fluorimetric assay for the rapid determination of histamine in biological fluids. Life Sci II. 1973 Apr 8;12(7):327–336. doi: 10.1016/0024-3205(73)90366-4. [DOI] [PubMed] [Google Scholar]
- Goose J., Blair A. M. Passive cutaneous anaphylaxis in the rat, induced with two homologous reagin-like antibodies and its specific inhibition with disodium cromoglycate. Immunology. 1969 Jun;16(6):749–760. [PMC free article] [PubMed] [Google Scholar]
- Howell J. B., Altounyan R. E. A double-blind trial of disodium cromoglycate in the treatment of allergic bronchial asthma. Lancet. 1967 Sep 9;2(7515):539–542. doi: 10.1016/s0140-6736(67)90499-0. [DOI] [PubMed] [Google Scholar]
- Ishizaka K., Ishizaka T. Biological function of gamma E antibodies and mechanisms of reaginic hypersensitivity. Clin Exp Immunol. 1970 Jan;6(1):25–42. [PMC free article] [PubMed] [Google Scholar]
- Johansson S. G., Bennich H. H., Berg T. The clinical significance of IgE. Prog Clin Immunol. 1972;1:157–181. [PubMed] [Google Scholar]
- MOTA I. THE MECHANISM OF ANAPHYLAXIS. I. PRODUCTION AND BIOLOGICAL PROPERTIES OF 'MAST CELL SENSITIZING' ANTIBODY. Immunology. 1964 Nov;7:681–699. [PMC free article] [PubMed] [Google Scholar]
- Mota I. Biological characterization of mouse 'early' antibodies. Immunology. 1967 Mar;12(3):343–348. [PMC free article] [PubMed] [Google Scholar]
- Ogilvie B. M. Reagin-like antibodies in rats infected with the nematode parasite Nippostrongylus brasiliensis. Immunology. 1967 Feb;12(2):113–131. [PMC free article] [PubMed] [Google Scholar]
- Orr T. S., Hall D. E., Gwilliam J. M., Cox O. S. The effect of disodium cromoglycate on the release of histamine and degranulation of rat mast cells induced by compound 48-80. Life Sci I. 1971 Jul 15;10(14):805–812. doi: 10.1016/0024-3205(71)90035-x. [DOI] [PubMed] [Google Scholar]
- Pepys J. Immunopathology of allergic lung disease. Clin Allergy. 1973 Mar;3(1):1–22. doi: 10.1111/j.1365-2222.1973.tb01304.x. [DOI] [PubMed] [Google Scholar]
- Pfister J. R., Ferraresi R. W., Harrison I. T., Rooks W. H., Roszkowski A. P., Van Horn A., Fried J. H. Xanthone-2-carboxylic acids, a new series of antiallergic substances. J Med Chem. 1972 Oct;15(10):1032–1035. doi: 10.1021/jm00280a010. [DOI] [PubMed] [Google Scholar]
- SHORE P. A., BURKHALTER A., COHN V. H., Jr A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther. 1959 Nov;127:182–186. [PubMed] [Google Scholar]
- Sheard P., Blair A. M. Disodium cromoglycate. Activity in three in vitro models of the immediate hypersensitivity reaction in lung. Int Arch Allergy Appl Immunol. 1970;38(2):217–224. [PubMed] [Google Scholar]
- Stechschulte D. J., Austen K. F., Bloch K. J. Antibodies involved in antigen-induced release of slow reacting substance of anaphylaxis (SRS-A) in the guinea pig and rat. J Exp Med. 1967 Jan 1;125(1):127–147. doi: 10.1084/jem.125.1.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Taylor W. A., Roitt I. M. Effect of disodium cromoglycate on various types of anaphylactic reaction in the guinea pig. Int Arch Allergy Appl Immunol. 1973;45(6):795–807. doi: 10.1159/000231080. [DOI] [PubMed] [Google Scholar]
- Thomson D. S., Evans D. P. Inhibition of immediate hypersensitivity reactions by disodium cromoglycate. Clin Exp Immunol. 1973 Apr;13(4):537–544. [PMC free article] [PubMed] [Google Scholar]
